Population pharmacokinetic model‐guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction-Reference-Cited by-同舟云学术

Population pharmacokinetic model‐guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction

Published:2021-10-25 Issue:1 Volume:42 Page:23-33
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Lin Xiao‐bin¹,Lui Ka Yin²,Guo Peng‐hao³,Liu Xiao‐man¹,Liang Tao¹,Hu Xiao‐guang²,Tong Li²,Wu Jing‐jing¹,Xia Yan‐zhe¹,Chen Pan¹,Zhong Guo‐ping⁴,Chen Xiao¹,Cai Chang‐jie²^ORCID

Affiliation:

1. Department of Pharmacy The First Affiliated Hospital Sun Yat‐sen University Guangzhou China

2. Department of Critical Care Medicine The First Affiliated Hospital Sun Yat‐sen University Guangzhou China

3. Department of Clinical Laboratory The First Affiliated Hospital Sun Yat‐sen University Guangzhou China

4. Institute of Clinical Pharmacology School of Pharmaceutical Sciences Sun Yat‐sen University Guangzhou China

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2634

Reference37 articles.

1. Necessity for a Significant Maintenance Dosage Reduction of Voriconazole in Patients with Severe Liver Cirrhosis (Child–Pugh Class C)

2. Invasive aspergillosis in patients with severe alcoholic hepatitis

3. Risk Factors for Invasive Pulmonary Aspergillosis and Hospital Mortality in Acute-On-Chronic Liver Failure Patients: A Retrospective-Cohort Study

4. Pharmacokinetic/Pharmacodynamic Profile of Voriconazole

5. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic implementation for CYP2C19 and pharmacokinetics of voriconazole in children with malignancy or inborn errors of immunity;Journal of Infection and Chemotherapy;2024-06

2. Renal Replacement Therapy as a New Indicator of Voriconazole Clearance in a Population Pharmacokinetic Analysis of Critically Ill Patients;Pharmaceuticals;2024-05-22

3. Enhancing voriconazole therapy in liver dysfunction: exploring administration schemes and predictive factors for trough concentration and efficacy;Frontiers in Pharmacology;2024-01-04

4. Population Pharmacokinetics of Voriconazole and Dose Optimization in Elderly Chinese Patients;The Journal of Clinical Pharmacology;2023-10-16

5. The impact of gene polymorphism and hepatic insufficiency on voriconazole dose adjustment in invasive fungal infection individuals;Frontiers in Genetics;2023-08-24